Episcleritis is an inflammation of the episclera, the thin layer of tissue that covers the white part of the eye (the sclera). It is a relatively uncommon condition, with an estimated incidence of 5-10 cases per 100,000 people per year. Episcleritis is usually a benign condition, although it can be painful and may cause redness and discomfort in the affected eye. It is important for doctors to be aware of the signs and symptoms of episcleritis in order to diagnose and treat the condition quickly and effectively.
The exact cause of episcleritis is not known. However, it is believed to be related to an underlying inflammatory process. It has been associated with autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and Sjogren’s syndrome. In some cases, it may be caused by an infection or an allergy.
The most common symptom of episcleritis is redness of the affected eye. The redness may be localized to the area around the eye or may spread across the entire surface of the eye. Other symptoms may include itching, tearing, pain, and sensitivity to light. In some cases, the affected eye may become swollen or have a gritty feeling.
The diagnosis of episcleritis is usually based on a physical examination and the patient’s symptoms. The doctor may also perform a slit-lamp examination, which is an examination of the eye using a special microscope. This allows the doctor to look for signs of inflammation in the episclera. In some cases, the doctor may also perform tests to rule out other conditions, such as an infection or an allergy.
The treatment of episcleritis depends on the underlying cause. In most cases, the condition resolves on its own without treatment. However, if the condition is severe or does not improve with time, the doctor may prescribe medications to reduce inflammation and pain. These medications may include corticosteroids, anti-inflammatory drugs, or antibiotics. In some cases, the doctor may also recommend using artificial tears to reduce discomfort.
The best way to prevent episcleritis is to avoid triggers that may lead to inflammation. These triggers may include allergens, infections, and certain medications. It is also important to practice good hygiene, such as washing the hands regularly and avoiding contact with people who have an infection.
Episcleritis is an inflammation of the episclera, the thin layer of tissue that covers the white part of the eye (the sclera). It is usually a benign condition, although it can be painful and may cause redness and discomfort in the affected eye. It is important for doctors to be aware of the signs and symptoms of episcleritis in order to diagnose and treat the condition quickly and effectively. Treatment of episcleritis depends on the underlying cause, and may include medications to reduce inflammation and pain. The best way to prevent episcleritis is to avoid triggers that may lead to inflammation.
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation